Parataxis Holdings LLC, a Bitcoin investment firm, has finalized a 25 billion won ($19.5 million) investment agreement with Bridge Biotherapeutics, Inc. This deal allows Parataxis to acquire a controlling stake in Bridge Biotherapeutics, which will be renamed Parataxis Korea and remain listed on the KOSDAQ market. Further details of the transaction will be disclosed following a shareholders meeting in August. Additionally, Parataxis Holdings plans to go public through a merger with SilverBox Corp IV, having signed a non-binding letter of intent.